pillbase.ru

Prevymis

Active substance: letermovir

Letermovir

Centralised EU authorisationActive

Marketing holder: Merck Sharp & Dohme B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 6
  • PREVYMIS
    INJECTION, SOLUTION · LETERMOVIR 20 mg/mL
    0006-5004
    Merck Sharp & Dohme LLC
  • PREVYMIS
    INJECTION, SOLUTION · LETERMOVIR 20 mg/mL
    0006-5003
    Merck Sharp & Dohme LLC
  • PREVYMIS
    PELLET · LETERMOVIR 120 mg/1
    0006-5085
    Merck Sharp & Dohme LLC
  • PREVYMIS
    TABLET, FILM COATED · LETERMOVIR 240 mg/1
    0006-3075
    Merck Sharp & Dohme LLC
  • PREVYMIS
    PELLET · LETERMOVIR 20 mg/1
    0006-5086
    Merck Sharp & Dohme LLC
All products in this country (6)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-12bc-7186-9671-a81e79bff2dd,01a1208e-319f-7d5a-82fb-e0508576c8c4,01a1208f-a56f-7ed0-886b-b35abbdd1305,01a12098-2c81-7b33-9a0a-b6b67160dd3b,01a1209a-df80-766a-9f41-503e4540a312;count=6 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004536
Registration status
Active
ATC code
J05
Sources
  • product · EMA · EMEA/H/C/004536 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004536 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004536 · Verified 2026-10-09